Showing results (951-960 of 2,020) with videos related to

Sort By:
Pageof 202
Transactions of the Royal Society of Tropical Medicine and Hygiene|February 17, 1998
Absence of malaria-specific mortality in children in an area of hyperendemic malariaK Maitland, T N Williams, T E Peto, et al.
Advances in Experimental Medicine and Biology|October 3, 2019
Resolution of Cellular Heterogeneity in Human Prostate Cancers: Implications for Diagnosis and TreatmentNorman J Maitland, Fiona M Frame, Jayant K Rane, et al.
The Journal of Antimicrobial Chemotherapy|February 22, 2005
Boosted saquinavir hard gel formulation exposure in HIV-infected subjects: ritonavir 100 mg once daily versus twice dailyMarta Boffito, Desmond Maitland, Laura Dickinson, et al.
Journal of Applied Polymer Science|February 27, 2018
Examination of radio-opacity enhancing additives in shape memory polyurethane foamsAndrew C Weems, Jeffery E Raymond, Kevin T Wacker, et al.
American Journal of Respiratory and Critical Care Medicine|September 10, 2005
Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertensionMardi Gomberg-Maitland, Victor F Tapson, Raymond L Benza, et al.
Journal of Clinical Pharmacology|December 31, 2013
Technical considerations in the development of circulating peptides as pharmacodynamic biomarkers for angiogenesis inhibitorsVasiliki Thomeas, Selina Chow, Jose O Gutierrez, et al.
Pharmacogenetics and Genomics|May 3, 2005
A multilocus approach to the antihypertensive pharmacogenetics of hydrochlorothiazideAnke-Hilse Maitland-van der Zee, Stephen T Turner, Gary L Schwartz, et al.
Chest|March 16, 2006
Safety and efficacy of IV treprostinil for pulmonary arterial hypertension: a prospective, multicenter, open-label, 12-week trialVictor F Tapson, Mardi Gomberg-Maitland, Vallerie V McLaughlin, et al.
Research Quarterly for Exercise and Sport|February 2, 2013
Adolescents' self-efficacy to overcome barriers to Physical Activity ScaleJohn J M Dwyer, Tala Chulak, Scott Maitland, et al.
British Journal of Haematology|February 1, 1989
In vitro studies of ways to overcome resistance to VAMP--high dose melphalan in the treatment of multiple myelomaB C Millar, J B Bell, J A Maitland, et al.
Pageof 202